SCHEMBL97374

SCHEMBL97374

CCC(=O)OC1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.60
EPHX1 P07099 2/20 0.53
HTT P42858 2/20 0.52
CYP2C19 P33261 1/20 0.50
CYP19A1 P11511 3/20 0.46
CHRM2 P08172 2/20 0.44
CHRM4 P08173 2/20 0.44
CHRM1 P11229 2/20 0.44
CHRM3 P20309 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29626573 0.98 NAAA (0.58) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL183236 0.98 NAAA (0.61) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL1695751 0.98 NAAA (0.61) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL1595662 0.98 NAAA (0.61) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL9577043 0.96 NAAA (0.59) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL7905393 0.96 NAAA (0.59) NAAAEPHX1HTTCYP2C19CYP19A1
Hydrochloric Acid SCHEMBL22466282 0.96 NAAA (0.59) NAAAEPHX1HTTCYP2C19CYP19A1
SCHEMBL3631877 0.95
Hydrochloric Acid SCHEMBL32661951 0.93 NAAA (0.53) NAAAEPHX1HTTCYP2C19CYP19A1
Benzene SCHEMBL10901065 0.92 NAAA (0.56) NAAAEPHX1HTTCYP2C19CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 7059 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260103492-A1 CYCLOSPORINE COMPOSITIONS AND METHODS OF USE BACAINN BIOTHERAPEUTICS, LTD. (KY) 2026-04-16 US claimed
EP-3766496-B1 ANLOTINIB FOR TREATMENT OF NASOPHARYNGEAL CARCINOMA CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2026-02-25 EP claimed
US-20250367187-A1 QUINOLINE DERIVATIVE USED FOR TREATING SMALL CELL LUNG CANCER CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2025-12-04 US claimed
US-12472173-B2 Quinoline derivative and antibody soft tissue sarcoma combination therapy CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2025-11-18 US claimed
US-12421281-B2 Cyclosporine compositions and methods of use BACAINN BIOTHERAPEUTICS, LTD. (KY) 2025-09-23 US claimed
EP-3957631-B1 QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2025-09-10 EP claimed
CN-118281153-B Composite anode material and preparation method and application thereof 成都工业学院 2025-03-21 CN claimed
CN-114787161-B Pyrazolo [1,5-a ] pyridine compound, and preparation method and application thereof 深圳众格生物科技有限公司 2024-08-02 CN claimed
CN-118281153-A Composite anode material and preparation method and application thereof 成都工业学院 2024-07-02 CN claimed
CN-116354792-B Method for preparing cyclopentanol from cyclopentene 福州大学 2024-06-04 CN claimed
WO-2005013694-A1 INSECT REPULSIVE ALLOMONES FIDELINE (FR) 2005-02-17 WO claimed
EP-1456322-A1 GLYCERIN TRIESTER PLASTICIZER FERRO CORPORATION (US) 2004-09-15 EP claimed
US-6740254-B2 PHTHALATE-FREE PLASTICIZER INCLUDES A MIXTURE TRIESTERS OF GLYCERIN, ATLEAST TWO SELECTED FROM GYCERYL(1,2)BIBUTANOATE BENZOATE, GLYCERYL(1,3)BISBUTANOATE BENZOATE, GLYCERYL(1,2 OR 1,3)BISBENZOATE BUTANOATES FERRO CORPORATION 2004-05-25 US claimed
WO-2003054106-A1 GLYCERIN TRIESTER PLASTICIZER FERRO CORPORATION (US) 2003-07-03 WO claimed
US-20030116750-A1 Glycerin triester plasticizer POLYMER ADDITIVES, INC. 2003-06-26 US claimed
US-20030120104-A1 Glycerin triester plasticizer FERRO CORPORATION (US) 2003-06-26 US claimed
CN-1422156-A Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections PHARMACIA CORP (US) 2003-06-04 CN claimed
CN-1328457-A Use of N-substituted 1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections SEARLE & CO (US) 2001-12-26 CN claimed
CN-1050130-C Naloxonate and naltrexonate and series product and preparation method LU ZHENGTANG (CN) 2000-03-08 CN claimed
CN-1204649-A Naloxonate and naltrexonate and series product and preparation method LU ZHENGTANG (CN) 1999-01-13 CN claimed